down-arrowleft-arrowright-arrow

Jason Kanter Associate

I draw on my scientific training to understand patented technologies and to craft stories that resonate at trial and ensure the best outcome for our clients.

LOCATION

New York

+1.212.588.0800

745 Fifth Avenue, 10th Floor,
New York, NY 10151

VIEW IN MAPS
  • Jason Kanter works in the New York office of Haug Partners and is an experienced trial attorney who has represented clients in litigations at the both district-court level and before the United States Court of Appeals for the Federal Circuit. His practice focuses on intellectual property litigation, counseling, and opinion work. With a deep background in the life sciences, Mr. Kanter has a particular expertise in the intersection of science and law and how scientific and technical issues impact a client’s case. Mr. Kanter is also a patent agent and is part of the firm’s patent prosecution practice. With an award winning education, Mr. Kanter thrives in the firm’s entrepreneurial environment that calls on all employees to leverage their unique skills and expertise for the full benefit if its clients.
  • The Medicines Company v. Hospira, Inc., 14-1469 (Fed. Cir.) (en banc)
  • The Medicines Company v. Mylan, Inc., et al., 15-1113 (Fed. Cir.)
  • Shire Development, LLC. v. Watson Pharmaceuticals, Inc., et al., 12-60862 (S.D. Fla.)
  • The Medicines Company v. Mylan Inc. et al., 11-1285 (N.D. Ill.)
  • The Medicines Company v. Teva Parenteral Medicines, Inc., APP Pharmaceuticals, LLC, Hospira Inc. et al., 09-750 (D. Del.)
  • Understanding and Incentivizing Biosimilars, 64 HASTINGS L.J. at 58-82 (Dec.2012) (with Robin Feldman).
  • Executive Administrative Editor for the Hastings Science and Technology Law Journal
  • Received both CALI and Witkin Awards in each of the following areas: Patent Prosecution, Patent Litigation, Food and Drug Law, and Client Counseling
  • University of California, Los Angeles, 2007, B.S., Microbiology, Immunology, and Molecular Genetics
  • Northwestern University, McCormick School of Engineering, 2008, M.S., Biotechnology
  • University of California, Hastings College of the Law, 2012, J.D., Intellectual Property Concentration
  • Intellectual Property Enforcement
  • Intellectual Property Procurement and Strategy
  • Commercial, Business, and Shareholder Litigation and Strategic Counseling Services
  • FDA Compliance and Counseling
  • New York
  • U.S. Court of Appeals for the Federal Circuit
  • Registered to practice before the U.S. Patent and Trademark Office
  • Federal Circuit Bar Association
  • New York Intellectual Property Law Association

+1.212.588.0800
jkanter@haugpartners.com

RELATED SERVICES

  • Intellectual Property Enforcement
  • Intellectual Property Procurement and Strategy
  • Commercial, Business, and Shareholder Litigation and Strategic Counseling Services
  • FDA Compliance and Counseling

BAR ADMISSIONS

  • New York
  • U.S. Court of Appeals for the Federal Circuit
  • Registered to practice before the U.S. Patent and Trademark Office

Haug Partners LLP
745 Fifth Avenue, 10th Floor,
New York, NY 10151
+1.212.588.0800
haugpartners.com

Jason Kanter

Associate

HIGHLIGHT

I draw on my scientific training to understand patented technologies and to craft stories that resonate at trial and ensure the best outcome for our clients.

OVERVIEW

Jason Kanter works in the New York office of Haug Partners and is an experienced trial attorney who has represented clients in litigations at the both district-court level and before the United States Court of Appeals for the Federal Circuit. His practice focuses on intellectual property litigation, counseling, and opinion work. With a deep background in the life sciences, Mr. Kanter has a particular expertise in the intersection of science and law and how scientific and technical issues impact a client’s case. Mr. Kanter is also a patent agent and is part of the firm’s patent prosecution practice. With an award winning education, Mr. Kanter thrives in the firm’s entrepreneurial environment that calls on all employees to leverage their unique skills and expertise for the full benefit if its clients.

REPRESENTATIVE CASES

  • The Medicines Company v. Hospira, Inc., 14-1469 (Fed. Cir.) (en banc)
  • The Medicines Company v. Mylan, Inc., et al., 15-1113 (Fed. Cir.)
  • Shire Development, LLC. v. Watson Pharmaceuticals, Inc., et al., 12-60862 (S.D. Fla.)
  • The Medicines Company v. Mylan Inc. et al., 11-1285 (N.D. Ill.)
  • The Medicines Company v. Teva Parenteral Medicines, Inc., APP Pharmaceuticals, LLC, Hospira Inc. et al., 09-750 (D. Del.)

PUBLICATIONS

  • Understanding and Incentivizing Biosimilars, 64 HASTINGS L.J. at 58-82 (Dec.2012) (with Robin Feldman).
  • Executive Administrative Editor for the Hastings Science and Technology Law Journal

AWARDS

  • Received both CALI and Witkin Awards in each of the following areas: Patent Prosecution, Patent Litigation, Food and Drug Law, and Client Counseling

EDUCATION

  • University of California, Los Angeles, 2007, B.S., Microbiology, Immunology, and Molecular Genetics
  • Northwestern University, McCormick School of Engineering, 2008, M.S., Biotechnology
  • University of California, Hastings College of the Law, 2012, J.D., Intellectual Property Concentration

BAR ADMISSIONS

  • New York
  • U.S. Court of Appeals for the Federal Circuit
  • Registered to practice before the U.S. Patent and Trademark Office

MEMBERSHIPS

  • Federal Circuit Bar Association
  • New York Intellectual Property Law Association